NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
Back to search
Official data from USPTO
KIROMIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/16/2025
Trademark type
Combined
Nice classes
5
Filing date
06/30/2022
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
04/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/09/2024
First use in commerce
12/09/2024
Drawing code
3
Owner type
03
Owner location
Houston, TX
Examiner
MICKLEBURGH, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word KIROMIC and the letter O of the word represents a sun.
Holders and representatives
Holders
Kiromic Biopharma, Inc.
Representatives
Karen Won MINTZ, LEVIN, COHN, FERRIS, GLOVSKY, AND POPEO P.C
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalbiologicbiopharmaceutical preparations for use in oncologyimmunologyimmuno-oncology; Biopharmaceutical preparationscell therapiesgene therapies for preventingmanagingtreating diseases and disorders in oncologyimmunologyimmuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological componentsengineered and edited human cellsbeing a component in therapeutic preparations for use in diseases and disorders of oncologyimmunologyimmune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targetingdeliveryeffectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
Publications
History of USPTO decisions and trademark events.
39 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/21/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/21/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/12/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/12/2025
EX4G
SOU EXTENSION 4 GRANTED
03/12/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/12/2025
IUAF
USE AMENDMENT FILED
01/07/2025
EXT4
SOU EXTENSION 4 FILED
01/07/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/07/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/18/2024
EX3G
SOU EXTENSION 3 GRANTED
07/18/2024
EXT3
SOU EXTENSION 3 FILED
07/18/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/18/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/14/2023
EX2G
SOU EXTENSION 2 GRANTED
12/12/2023
EXT2
SOU EXTENSION 2 FILED
12/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/11/2023
EX1G
SOU EXTENSION 1 GRANTED
07/08/2023
EXT1
SOU EXTENSION 1 FILED
07/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/08/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2022
PUBO
PUBLISHED FOR OPPOSITION
11/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2022
GNRT
NON-FINAL ACTION E-MAILED
10/05/2022
CNRT
NON-FINAL ACTION WRITTEN
10/05/2022
DOCK
ASSIGNED TO EXAMINER
10/03/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2022
NWAP
NEW APPLICATION ENTERED
07/04/2022
Continuous trademark protection
Get notified about every new filing that threatens KIROMIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.